Inventor · disambiguated record
Hao Tang
Also filed as: TANG HAO · Tang hao-yuan
12 granted patents·5 pending applications·41 citations·filing 2014–2022
88Inventor score
Files withAGENUS INC8RAYBIOTECH LIFE INC3CHEN XIAOCHUN1JIANGSU PACIFIC MEINUOKE BIO PHARMACEUTICAL CO LTD1METAL IND RES & DEV CT1
Top patents by PatentIndex Score
17 records- 0196US10626181B2Nucleic acids encoding anti-OX40 antibodiesAGENUS INC·Filed 2019·Granted Apr 21, 2020·7 cites·35 claims
- 0295US10259882B2Anti-OX40 antibodiesAGENUS INC·Filed 2016·Granted Apr 16, 2019·16 cites·47 claims
- 0393US11255855B1COVID-19 spike-ACE2 binding assay for drug and antibody screeningRAYBIOTECH LIFE INC·Filed 2021·Granted Feb 22, 2022·3 cites·3 claims
- 0493US11249083B1Covid-19 spike-ACE2 binding assay for drug and antibody screeningRAYBIOTECH LIFE INC·Filed 2021·Granted Feb 15, 2022·7 cites·13 claims
- 0590US11105804B1COVID-19 spike-ACE2 binding assay for drug and antibody screeningRayBiotech Life·Filed 2021·Granted Aug 31, 2021·5 cites·3 claims
- 0685US11472883B2Methods of administering anti-OX40 antibodiesAGENUS INC·Filed 2020·Granted Oct 18, 2022·1 cites·15 claims
- 0785US11332536B2Vectors comprising nucleic acids encoding anti-OX40 antibodiesAGENUS INC·Filed 2020·Granted May 17, 2022·1 cites·22 claims
- 0884US11136404B2Anti-OX40 antibodiesAGENUS INC·Filed 2019·Granted Oct 5, 2021·1 cites·64 claims
- 0984US2023167186A1Methods of administering anti-ox40 antibodiesAGENUS INC·Filed 2022·Application pending·0 cites
- 1084US2023108348A1Methods of administering anti-ox40 antibodiesAGENUS INC·Filed 2022·Application pending·0 cites
- 1179US2022098316A1Anti-ox40 antibodies and methods of use thereofAGENUS INC·Filed 2021·Application pending·0 cites
- 1249US11137395B1SARS-CoV-2 (COVID-19) spike-AXL binding assayRAYBIOTECH LIFE INC·Filed 2021·Granted Oct 5, 2021·0 cites·9 claims
- 1343US2020170698A1Medical torque hand toolMETAL IND RES & DEV CT·Filed 2019·Application pending·0 cites
- 1442US11027016B2Pharmaceutical preparation stably comprising CD147 monoclonal antibodyCHEN XIAOCHUN·Filed 2017·Granted Jun 8, 2021·0 cites·4 claims
- 1542US2015017210A1Gene Signature Predicts Adenocarcinoma Prognosis and Therapeutic ResponseUNIV TEXAS·Filed 2014·Application pending·0 cites
- 1639US11053317B2Pharmaceutical preparation stably comprising CD147 monoclonal antibodyJIANGSU PACIFIC MEINUOKE BIO PHARMACEUTICAL CO LTD·Filed 2017·Granted Jul 6, 2021·0 cites·3 claims
- 1729US10855608B1Reconnect restriction evaluatorMICROSOFT TECHNOLOGY LICENSING LLC·Filed 2016·Granted Dec 1, 2020·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Hao Tang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →